Business ❯Finance ❯Investment Strategies

Analyst Recommendations

Stock Market Market Trends Investment Strategies Corporate Finance Market Analysis Investments Earnings Reports Drug Development Pharmaceuticals Corporate Performance

UBS Upgrades Bharat Electronics, Sets ₹450 Target on Strong Growth Prospects

The investment bank cites accelerated order pipeline, robust margins, and competitive edge as reasons for preferring BEL over HAL.

Cintas Reports Strong Q3 Results, Terminates UniFirst Acquisition

Biogen Reports Mixed Q4 Results and Lowers 2025 Outlook

Skyworks Stock Drops 25% Following Apple’s Shift to Dual-Sourcing Strategy

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

Uber Reports Strong Q4 but Stock Drops on Soft Forecast and FX Challenges

Johnson & Johnson Exceeds Q4 Expectations with Strong Cancer Drug Sales